NOT-CA-10-014: Participation of NCI in RFA-OD-10-008, Recovery Act Limited Competition: Comparative Effectiveness Research on Upper Endoscopy in Gastroesophageal Reflux Disease (GERD), Eradication Methods for Methicillin Resistant Staphylococcus aureus (MRSA), and Dementia Detection and Management Strategies (RC4)

Participation of NCI in RFA-OD-10-008, Recovery Act Limited Competition: Comparative Effectiveness Research on Upper Endoscopy in Gastroesophageal Reflux Disease (GERD), Eradication Methods for Methicillin Resistant Staphylococcus aureus (MRSA), and Dementia Detection and Management Strategies (RC4)

Notice Number: NOT-CA-10-014

Key Dates
Release Date: January 12, 2010
Opening Date: January 26, 2010 (Earliest date an application may be submitted to Grants.gov)
Application Due Date(s): February 26, 2010

Issued by
National Cancer Institute (NCI), (http://www.cancer.gov/)

Purpose

This Notice is to inform applicants that the National Cancer Institute announces its participation, effective immediately, in RFA-OD-10-008, entitled “Recovery Act Limited Competition: Comparative Effectiveness Research on Upper Endoscopy in Gastroesophageal Reflux Disease (GERD), Eradication Methods for Methicillin Resistant Staphylococcus aureus (MRSA), and Dementia Detection and Management Strategies (RC4)” (http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-008.html). Participation in this Funding Opportunity Announcement by the National Institute on Aging (NIA), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and National Institute of Mental Health (NIMH), continues, and is unaffected by this Notice.

Inquiries

For questions regarding this Notice, please contact:

Referral Officer
Division of Extramural Activities
National Cancer Institute
6116 Executive Boulevard, Room 8047
Bethesda, MD 20892-8329
Telephone: (301) 435-3428
Fax: (301) 402-0275
Email: [email protected]